Contact us to get started

Hope begins here.

If you're an HR or benefits professional seeking cancer resources for your employees, or a consultant looking to provide best-in-class cancer support for your clients, share a few details below. We’ll reach out to help your company get started.

If you’re an employee looking for your AccessHope benefit, call 800.423.3232 and select Option 1.

How we support community oncologists

Your ally and advocate with NCI expertise

As oncologic innovation continues to develop at an extraordinary pace, you can connect to our specialists at National Cancer Institute (NCI)–Designated Comprehensive Cancer Centers for no-cost support. If your patient is eligible for our employee benefit of cancer support services through their employer, our cancer subspecialists can provide insights into the latest advancements in their specific area of cancer expertise.

We proudly partner with NCI-centers to remotely deliver the latest cancer knowledge to the people and places who need it most.

Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

Read More

Fred Hutchinson Cancer Center

Fred Hutchinson Cancer Center

Read More

Johns Hopkins Medicine

Kimmel Cancer Center

Read More

Northwestern Medicine

Northwestern Medicine

Read More

UT Southwestern Medical Center

Harold C. Simmons Comprehensive Cancer Center

Read More

City of Hope

City of Hope is a world renowned cancer research and treatment center based in southern California. It is a National Cancer Institute-designated comprehensive cancer center, in addition to being a founding member of the National Comprehensive Cancer Network, making it a national leader in advancing research and treatment protocols. For over a decade, City of Hope has been identified as one of the nation’s elite cancer hospitals by U.S. News & World Report.

Visit Website
close button

Dana-Farber Cancer Institute

Dana-Farber Cancer Institute in Boston, MA is a Harvard Medical School teaching hospital. It is the #1 ranked cancer hospital in New England by US News & World Report. Nationwide, it is the only cancer hospital to be ranked in the top 5 for both adult and pediatric oncology care. Dana-Farber is dedicated to a unique balance of cancer care and research, translating discovery into new therapies for patients around the world and offering more than 1,100 clinical trials.

Dana-Farber is a founding member of the Dana-Farber/Harvard Cancer Center (DF/HCC), an NCI-designated Comprehensive Cancer Center, a founding member of the National Comprehensive Cancer Network, the top academic recipient of grant funding from the National Cancer Institute (NCI), and has the most highly cited research of any U.S. cancer center.

Visit Website
close button

Emory Healthcare

Emory Healthcare, with more than 24,000 employees and 11 hospitals, is the most comprehensive academic health system in Georgia. System-wide, it has 2,796 licensed patient beds, more than 2,800 physicians practicing in more than 70 specialties, serving metro Atlanta with 250 locations. It also provides services to greater Georgia through a joint venture at St. Francis–Emory Healthcare Hospital in Columbus, 10 regional affiliate hospitals, and its clinically integrated physician network.

As the National Cancer Institute (NCI)-designated comprehensive cancer center for the state of Georgia, Winship Cancer Institute of Emory University discovers, develops and delivers some of the world's most effective ways to prevent, detect, diagnose and treat each patient's unique cancer. Winship leverages the depth and breadth of Emory University and collaborates with other NCI-designated cancer centers and leading cancer organizations. Winship investigators conducted more than 300 therapeutic clinical trials and enrolled more than 900 patients in 2020. Winship has more than 500 faculty and received $80 million in cancer research funding in 2020, $33 million of that from the NCI.

Visit Website
close button

Northwestern Medicine

Northwestern Medicine is a nationally recognized health system that provides world-class care.  Anchored by Northwestern Memorial Hospital, ranked No. 1 in Illinois and No. 9 in the nation by US News and World Report. Northwestern Medicine encompasses more than 200 locations including 10 hospitals, the Northwestern University Feinberg School of Medicine and The Robert H. Lurie Comprehensive Cancer Center. 

Backed by the Lurie Cancer Center, Northwestern Memorial Hospital is ranked #9 in the nation by US News and World Report and is part of a select group of National Cancer Institute (NCI) designated Comprehensive Cancer Centers. Dedicated to overcoming cancer through scientific discovery, the Lurie Cancer Center provides compassionate, leading edge cancer care in a state of the art facility.

Visit Website
close button

Fred Hutchinson Cancer Center

Fred Hutchinson Cancer Center combines adult cancer care and advanced scientific research, and has a history of discoveries that treat, cure and identify prevention strategies for cancer and infectious diseases. The organization was renamed in April 2022, following the merger of long-time partners, Fred Hutchinson Cancer Research Center and Seattle Cancer Care Alliance. Fred Hutchinson Cancer Center is an independent, nonprofit organization that serves as UW Medicine’s cancer program.

Fred Hutch has been a National Cancer Institute-designated cancer center since 1973. Global leadership in bone marrow transplantation, HIV/AIDS, immunotherapy and COVID-19 helped Fred Hutch earn recognition as one of the world’s leading cancer, infectious disease and biomedical research centers. Based in Seattle, Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy and related services, and has network affiliations with hospitals in five states.

Visit Website
close button

Kimmel Cancer Center

As part of the Johns Hopkins Medicine academic health system and Johns Hopkins University School of Medicine, the Kimmel Cancer Center has five locations in the Baltimore and Greater Washington, D.C., regions. Designated by the National Cancer Institute as one of the first comprehensive cancer centers in the country, its physicians and scientists are recognized leaders throughout the nation and the world.

The Kimmel Cancer Center understands that each patient is unique and it provides a tailored approach to care by multidisciplinary teams of specialists. Its patients have access to a large number of clinical trials and supportive care resources for themselves and their caregivers. From immunotherapy and proton therapy, to molecular tumor board-guided treatments, its physicians, nurses, and pharmacists are dedicated to providing the best care possible backed by innovative research.

Visit Website
close button

Harold C. Simmons Comprehensive Cancer Center

Harold C. Simmons Comprehensive Cancer Center is the National Cancer Institute-designated Comprehensive Cancer Center of UT Southwestern Medical Center in Dallas, Texas. With 15 multidisciplinary teams interconnected to bring broad expertise to bear on challenges unique to different cancers, our providers facilitate access to compassionate, quality, leading-edge care including the latest in clinical trials. Simmons Cancer Center is a member of the National Comprehensive Cancer Network and ranked among the top 20 cancer centers in the nation by U.S. News & World Report.
Visit Website
close button UTSW Cancer Care Outpatient Building

With AccessHope,
community oncologists gain:

Remote NCI expertise

Obtain evidence-based recommendations associated with improved clinical outcomes. These recommendations may include the latest research findings and any suggested medications, tests, or clinical trials. With the support of our subspecialists, you can:

  • More quickly learn of emerging developments in cancer research and care

More time to focus on patient care

Maintain the top-quality care you provide every day, while we relieve your ever-evolving research tasks . Your patients remain entirely in your care, and close to home with their support system of family and friends.

Doctor-to-doctor communication

Directly engage with our subspecialists who focus on the latest research, discoveries, and treatments (including potential toxicities and side effects). While caring for your patients, you gain the extension of a support team who will:

  • Review your patient's medical records and treatment plan
  • Provide personalized recommendations, which you may choose to apply to the treatment plan at your discretion 

AccessHope takes the ever-growing body of cancer research and puts it to work for the greater good. This groundbreaking approach supports knowledge-sharing within the oncology community, while enabling our members to experience the best-possible outcomes. AccessHope offers a tremendous benefit for those touched by cancer—it means that anyone, anywhere, can benefit from today’s extraordinary innovations in oncology.

Dr. Todd Sachs Chief Medical Officer

Meet our clinical experts

These are the faces of the people who make AccessHope what it is:

Todd
Sachs, M.D.

Chief Medical Officer

Dr. Todd Sachs leads AccessHope’s clinical team and oversees the remote delivery of our cancer support services. Passionate about addressing healthcare disparities and promoting value-based care, Todd is deeply dedicated to staying in the know on the latest innovations in oncology, with the goal to help improve the quality and length of life for people touched by cancer.

 

Board certified by the American Board of Surgery and a fellow of the American College of Surgeons, Todd specializes in endocrine surgery of the thyroid and parathyroid glands. He also belongs to the California Medical Association and Los Angeles Surgical Society.

Joseph
Alvarnas, M.D.

Chief Clinical Advisor | AccessHope; VP, Government Affairs and Senior Medical Director for Employer Strategy, Clinical Professor, Hematology/HCT | City of Hope

Dr. Alvarnas is AccessHope’s Chief Clinical Advisor with a passion for changing the healthcare system to ensure the delivery of first-class cancer care. He’s also a Clinical Professor of Hematology, the Vice President of Government Affairs, and the Senior Medical Director for Employer Strategy at City of Hope, a world-renowned independent cancer research and treatment center. For the center, he leads advocacy efforts at the federal, state, and local levels, and assists in developing, marketing, and operationalizing the clinical infrastructure and activities related to employer and payer strategies.  

Debra
Wong, M.D.

Vice President, Development and Integration, Clinical Strategy and Medical Director | AccessHope | Assistant Professor, Department of Medical Oncology and Therapeutics Research | City of Hope

Dr. Wong is a board-certified medical oncologist and a Medical Director at AccessHope, where she holds dual roles in teleoncology for local oncologists and their patients, and organizational strategy development. She maintains broad expertise in solid tumor oncology and advocates for integrating supportive care and quality-of-life measures into precision oncology care. For her humanity and whole-person approach, she has earned recognition among peers and patients alike. 

Nitya
Nathwani, M.D., FACP

Medical Director | AccessHope | Associate Professor, Division of Multiple Myeloma and Department of Hematology and Hematopoietic Cell Transplantation | City of Hope

Dr. Nathwani is AccessHope’s Medical Director of hematologic malignancies, transplantation, and cellular therapy. He is a multiple myeloma specialist and is also an Associate Professor in the Division of Multiple Myeloma and the Department of Hematology and Hematopoietic Cell Transplantation at City of Hope. He has been the principal investigator at City of Hope for several high-profile clinical trials in multiple myeloma and led a study of older adults with the disease. The assessments performed by him, and his team were able to influence treatment decisions while potentially increasing the safety of myeloma therapy.

Need help?

We create innovative services that help patients navigate the sometimes overwhelming world of cancer care.

Our goal is to help treating oncologists and their patients access specialized cancer insights when in need, and achieve optimal outcomes.

Contact our support team

Peer-reviewed study validates AccessHope's remote model of providing expert case reviews in lung cancer

Download the full paper

Frequently Asked Questions

+-

What services does AccessHope Offer?

Accountable Precision Oncology – Following the diagnosis of certain rare or complex cancers, AccessHope automatically initiates an expert review for eligible patients whose health plan has contracted for our APO service. AccessHope identifies a subspecialist to review your eligible patient’s medical records and treatment plan. The subspecialist creates a written report to share with your patient’s health plan.

Expert Advisory Review – Your eligible patients initiate this review by contacting AccessHope and requesting to have their cancer diagnosis and treatment plan reviewed by our team of experts. AccessHope’s subspecialists provide written recommendations to you based on groundbreaking insights and leading discoveries to help ensure that your patient has access to relevant, emerging cancer research findings and an optimal treatment plan for their type of cancer. AccessHope works with you, the local treating oncologist, so that your patient can stay close to home. Your patient remains exclusively in your care, and you continue to oversee his or her treatment plan.

Cancer Support Team – Your eligible patients and their caregivers can connect with experienced oncology nurses when they have questions about appointments or treatments, or if they need emotional support. This support is non-clinical in nature, and provides a much-needed listening ear for your patients and their loved ones during their cancer journey, offering information and support.

+-

How much does AccessHope cost?

There is no cost to your practice or your eligible patients for AccessHope’s services – these services are a component of your eligible patient’s employer-sponsored health plan.

+-

Who is eligible for AccessHope services?

AccessHope contracts with employers and health plans to provide our cancer support services to millions of people across the United States.

+-

How does a patient enroll for AccessHope's services?

Patients do not enroll separately for AccessHope’s services. AccessHope’s services are a component of eligible patients’ employer-sponsored health plans. Eligible patients can contact AccessHope and we will confirm eligibility and help the patient initiate Expert Advisory Review and/or Cancer Support Team services. AccessHope’s Accountable Precision Oncology service is a service to the health plan, and is automatically initiated upon the health plan’s notification of a patient’s diagnosis of certain rare or complex cancers; the patient does not initiate the APO review.

+-

Does AccessHope help with clinical trials?

As a standard part of AccessHope’s Expert Advisory Review and Accountable Precision Oncology program, AccessHope identifies clinical trials that may be relevant to your patient. Where appropriate, AccessHope will evaluate patients’ eligibility for clinical trials. However, AccessHope doesn’t help facilitate or guarantee acceptance into clinical trials.

+-

At what point of the patient's cancer journey does AccessHope help?

Eligible patients can reach out and connect with any of AccessHope’s service at any stage in their cancer journey – whether they’ve just been diagnosed, have started treatment, or have previously been diagnosed with cancer.

+-

How does AccessHope work with our practice's oncologists?

For your eligible patients who have initiated an Expert Advisory Review, AccessHope’s clinical experts review the records of patients with complex cancers, provide written reports, and are available to discuss the cases with you, the treating physician, on a peer-to-peer basis. They remain available for consultation throughout the treatment period.

+-

Is the physician bound in any way to AccessHope's recommendations?

No. AccessHope recommendations are non-binding and treatment decisions remain with you and your patient.

+-

Does AccessHope help with clinical trials?

As a standard part of AccessHope’s Expert Advisory Review and Accountable Precision Oncology program, AccessHope identifies clinical trials which may be relevant to your patient. Where appropriate, AccessHope will evaluate patients’ eligibility for clinical trials. However, AccessHope doesn’t help facilitate or guarantee acceptance into clinical trials.

+-

At what point of the patient's cancer journey does AccessHope help?

Eligible patients can reach out and connect with any of AccessHope’s service at any stage in their cancer journey – whether they’ve just been diagnosed, have started treatment, or have previously been diagnosed with cancer.

+-

How does AccessHope work with our practice's oncologists?

For your eligible patients who have initiated an Expert Advisory Review, AccessHope’s clinical experts review the records of patients with complex cancers, provide written reports, and are available to discuss the cases with you, the treating physician, on a peer-to-peer basis. They remain available for consultation throughout the treatment period.

+-

Is the physician bound in any way to AccessHope's recommendations?

No. AccessHope recommendations are non-binding and treatment decisions remain with you and your patient.

Get to know us better.

Do you have a specific need, or want to speak with an AccessHope representative? We'll connect you with the right person.

Contact us to get started

NCI Support for Oncologists.

If you're a community oncologist interested in receiving helpful cancer resources, industry news, or information about AccessHope for your practice and its patients, please share a few details below.

When oncologists work together, everyone wins.

Stay in Touch

For the latest news, innovations, events, and updates from AccessHope, simply share your email address with us.

UT Southwestern Medical Center Partners with AccessHope to extend nationwide access to cancer expertise 

Read the Press Release